Skip to content

Clinical trials

Dyslipidemias trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Dyslipidemias Country / region: Germany Clear all

56 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20042
20054
200613
20072
20082
20092
20102
20123
20135
20141
20152
20161
20174
20181
20201
20212
20222
20231
20242
20253

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed41
Unknown status5
Recruiting4
Terminated4
Active, not recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Takeda11
Kowa Research Europe6
German Institute of Human Nutrition4
Novartis Pharmaceuticals4
Amgen3
University of Leipzig3
Eli Lilly and Company2
GWT-TUD GmbH2
Novartis2
Sanofi2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Dyslipidemias56
Diabetes Mellitus, Type 216
Hypercholesterolemia14
Glucose Metabolism Disorders11
Cardiovascular Diseases10
Diabetes Mellitus10
Hyperlipidemias9
Obesity8
Atherosclerosis5
Hypertension5

Trials

Showing 51 to 56 of 56. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.